BusnachG., Dal ColA., BrandoB.Different cascade filtration operating modalities in clinical use.Int J Artif Organs1988; 11: 493–6.
3.
FranceschiniG., BusnachG., CalabresiL.Predictability of low-density lipoprotein levels during apheretic treatment of hypercholesterolemia.Europ J Clin Invest1991; 21: 209–14.
4.
MineshimaM., AgishiT., HasuoY., KanekoI., Era Kf OtaK.Effect of membrane trapping in plasma fractionator on separative characteristics.Int J Artif Organs1988; 11: 191–4.
5.
ZborowskiM., MalcheskyP.S., DugganP.A., KooA.P.Membrane pore size and filtration selectivity in cryoglobulinemic plasma fractionation.Trans Am Soc Artif Internal Organs1991; 37: M490–1.
6.
ReinhartW.H., LutolfO., NydeggerU.R., MahlerF., StraubP.W.Plasmapheresis for hyperviscosity syndrome in macroglo-bulinemia Waldenstrom and multiple myeloma: influence on blood rheology and the microcirculation.J Lab Clin Med1992; 119: 69–76.
7.
SuehiroK., SueokaA., HorigushiJ.Clinical evaluation of plasmapheresis using newly developed high-performance EVAL secondary membrane (Evaflux 5A) for hypercholesterolemia. Presented at 30th Annual Meeting of Japanese Society of Artificial Organs, Tokyo, Nov. 5-6, 1992, Ref N° 636, p 1–22.
8.
BusnachG., BrandoB., Dal ColA.Cascade filtration with recirculation technique: effects on plasma protein composition. In: OdaT., ShiokawaY., InoueN., eds. Proc First International Congress of the World Apheresis Association, Tokyo 1986, ISAO Press, Cleveland, 1987; pp. 331–8.
